Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial- Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2688
https://www.valueinhealthjournal.com/article/S1098-3015(15)04764-6/fulltext
Title :
Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial- Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04764-6&doi=10.1016/j.jval.2015.09.2688
First page :
A713
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
2095